AMBI Subsidiary to Collect $1 Million in Damages; Nutrition 21 Settles Patent Infringement Claim.Business Editos & Health/Medical Writers PURCHASE, N.Y.--(BW HealthWire)--Feb. 21, 2001 AMBI AMBI Associação Médica Brasileira Iridologia Inc. (Nasdaq: AMBI) today announced that Nutrition 21, its ingredient subsidiary, will receive a $1 million payment from an unnamed company as a settlement of a chromium chromium (krō`mēəm) [Gr.,=color], metallic chemical element; symbol Cr; at. no. 24; at. wt. 51.996; m.p. about 1,857°C;; b.p. 2,672°C;; sp. gr. about 7.2 at 20°C;; valence +2, +3, +6. picolinate patent infringement patent infringement n. the manufacture and/or use of an invention or improvement for which someone else owns a patent issued by the government, without obtaining permission of the owner of the patent by contract, license or waiver. claim. Gail Montgomery, AMBI's President and Chief Executive Officer, commented, "Nineteen patent infringement suits have been filed in connection with AMBI's chromium picolinate franchise thus far. This is the largest of several settlements reached in recent months. Furthermore, while investigating this claim we uncovered evidence of additional infringement by others in the industry which we expect to result in further claims." "Nutrition 21 will continue to vigorously defend its intellectual property portfolio. This $1 million settlement, along with the monies recovered in other settlements, will be reinvested in an acceleration of our clinical development programs, brand building for Chromax(R) chromium picolinate, and the expansion of our patent enforcement efforts. These ongoing business initiatives will strengthen the significant competitive advantages enjoyed by our customers," continued Ms. Montgomery. Jon de la Harpe La Harpe is the name of several people in French history, among whom:
adj. Of, relating to, or resulting from metabolism. Metabolic Refers to the chemical processes of an organ or organism. reactions associated with chromium picolinate, and its effects on glycemic Glycemic The presence of glucose in the blood. Mentioned in: Cholesterol, High glycemic pertaining to the level of glucose in the blood. control and insulin regulation. Chromium picolinate holds promise for many new market applications, including cardiovascular health, mood regulation, and Syndrome X syndrome X n. A cluster of metabolic abnormalities, including insulin resistance, high blood levels of triglycerides, low blood levels of HDL-cholesterol, and obesity, that increase the risk of chronic diseases such as hypertension, coronary artery ." The nutritional uses for which chromium picolinate is sold are covered by Nutrition 21's patent estate, which among others, includes U.S. Patents 5,087,623 for the use of chromium picolinate for maintaining healthy blood sugar levels; 5,087,624 for promoting healthy lean body mass and weight loss; and 5,175,156 for supporting healthy cholesterol levels. The words "believe," "expect," "anticipate" and other similar expressions generally identify forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. . Forward-looking statements are based on the company's current expectations and are subject to market, competitive and regulatory factors and the other risks and uncertainties indicated from time to time in the company's filings with the Securities and Exchange Commission. Actual results can differ materially. The company makes no commitment to disclose any revisions to forward-looking statements. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion